Procertus Biopharm, Inc.

Madison, WI 53719

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.53MM
First Award Date 09/28/01
Most Recent Award Date 09/19/06

Key Personnel

Last Name Name Awards Contact
Kink John Kink 1
Fahl William E Fahl 1
Thunberg Allen Thunberg 2

4 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/19/06 - 05/31/08

Numerous clinical studies have described the negative impact of radiotherapy-induced dermatitis on cancer patients during and after their 5-6 week course of radiotherapy. Virtually all patients develop at least a mild dermatitis, and for almost half it's a painful side effect lasting weeks. There can be scarring, limitations on more aggressive r...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/23/05 - 08/31/06

Numerous clinical studies have described the negative impact of radiotherapy-induced dermatitis on cancer patients during and after their 5-6 week course of radiotherapy. Virtually all patients develop at least a mild dermatitis, and for almost half it's a painful side effect lasting weeks. There can be scarring, limitations on more aggressive r...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/13/03 - 07/31/04

DESCRIPTION (provided by applicant): Several recent clinical studies have described the side effect of radiation-induced dermatitis that occurs in the majority of cancer patients who receive radiotherapy. These same studies also report the lack of effective agents to prevent or treat this dermatitis. In some of these patients, the side effects a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/28/01 - 09/27/02
PI: John Kink

DESCRIPTION: (Verbatim) A National Institutes of Health study has indicated that "hair loss during cancer chemotherapy is probably the most troubling aspect of cancer treatment, it is psychologically debilitating and adds to the overall trauma of the cancer diagnosis and . treatment." We have developed a topical...